Introduction
Cochlin, a product of the COCH gene, is associated with an autosomal dominant sensorineural hearing loss referred to as DFNA9. The symptoms of DFNA9 include not only hearing loss but also vestibular disorders de Kok et al., 1999; Fransen et al., 1999; Grabski et al., 2003; Khetarpal, 1993; Manolis et al., 1996; Robertson et al., 1998; Usami et al., 2003; Verhagen et al., 1989 Verhagen et al., , 1992 . On light microscopic analysis, Khetarpal et al. [1991] and Khetarpal [1993] reported severe degeneration of the cochlea and vestibule in association with the deposition of an acidophilic ground substance in the spiral ligament, spiral limbus, spiral lamina and basilar membrane of DFNA9-affected ears. Robertson et al. [2006] also reported the loss of cellularity and the accumulation of an abundant homogeneous acellular eosinophilic deposit in the cochlea and vestibule of DFNA9-affected ears. They suggested that these extracellularly deposited aggregates contain mutated cochlin, and that this mutated cochlin alters the interactions between cochlin and other cochlin-associated proteins. Khetarpal [2000] compared the normal spiral ligament with that in DFNA9-affected ears at the ultrastructural level, and noted the absence of major fibrillar type II collagen bundles. We speculated that the proteins interacting with cochlin might include type II collagen and have previously re-ported that these two extracellular matrix (ECM) proteins coexist in the same fibrillar substance in the subepithelial area of the semicircular canal . This localization suggests that cochlin plays a role in structural homeostasis of the vestibule. At present, however, the exact role of cochlin, which accounts for 70% of the inner ear proteins [Ikezono et al., 2001] , remains incompletely understood.
Some clues that may help to elucidate the role of cochlin have, nevertheless, been reported. Since the sensorineural hearing loss observed in DFNA9 has a late onset and progresses slowly, the COCH gene has been implicated in this age-related hearing impairment . On the other hand, cochlin and type II collagen have been implicated in autoimmune hearing loss in humans [Baek et al., 2006; Yoo et al., 1984] . Further, Ikezono et al. [2009] recently reported that a short 16-kDa cochlin isoform (cochlin-tomoprotein) is specific to the perilymph and that this isoform could function as a diagnostic marker of perilymphatic fistula, which is related to hearing loss and vestibular disorder. Thus, we considered that it would be important to investigate the localization of cochlin in the cochlea, and in the present study we accordingly expanded our immuno-electromicroanalysis of cochlin to the cochlea. The role of cochlin in the cochlea, particularly in the basilar membrane, is also briefly discussed.
Materials and Methods

Antibodies
Cochlin has von Willebrand factor type A (vWFA)-like domains [Robertson et al., 2003 ]. We used a rabbit polyclonal antibody that recognizes all three cochlin isoforms. This was raised against the vWFA-like domain 1 of cochlin and has been previously described by Ikezono et al. [2004] . Briefly, a 19-mer (KADIAFLIDGSFNIGQRRF) peptide corresponding to residues 163-181 in the vWFA-like domain 1 was used to generate antibodies. The specificity of these antibodies for the corresponding antigenic peptide was confirmed by dot blot analysis and a peptide absorption test (data not shown). Antibodies against type II collagen (Chemicon International acquired by Millipore, Billerica, Mass., USA) were purchased commercially.
Tissue Processing
Wistar rats (body weight, 100-200 g) were anesthetized with pentobarbital (50 mg/kg body weight, i.p.) according to our institution's ethical regulations for the treatment of animals. A fixative of 4% paraformaldehyde and 0.1% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4) was perfused from the left ventricle, and the temporal bones were then isolated and immediately immersed in the same fixative. Thereafter, the cochleae were dissected under a stereomicroscope and further fixed for 2 h at 4 ° C.
The preparation of samples for embedding in Lowicryl K4M (Electron Microscopy Sciences, Fort Washington, Pa., USA) was performed according to a previously published procedure . Ultra-thin sections were cut using an ultramicrotome and mounted onto nickel grids (400 mesh).
Immunogold Labeling
The grid-mounted sections were immersed in a droplet (25 l) of 1% bovine serum albumin (BSA; Sigma, St. Louis, Mo., USA) in phosphate-buffered saline (PBS, 0.9% NaCl in 6.7 m M phosphate buffer, pH 7.2) for 1 h at room temperature, then incubated overnight at 4 ° C in a droplet of the optimal concentrations of rabbit antibodies against either cochlin (3.3 g/ml in BSA/PBS) or type II collagen (4 g/ml in BSA/PBS). After rinsing in PBS, the sections were incubated in colloidal gold-conjugated goat antirabbit IgG secondary antibody (diameter, 15 nm; BB International, Cardiff, UK) at 1: 50 dilution in BSA/PBS for 1 h at room temperature. Subsequently, the sections were washed with PBS and distilled water, and counterstained with uranyl acetate for 3 min and lead citrate for 30 s. These sections were then observed under a JEOL JEM-1220 electron microscope. As a negative control, preimmune rabbit IgG (4 g/ml in BSA/PBS) was used instead of the primary antibody.
This study protocol was approved by the Hamamatsu University School of Medicine Animal Use Committee.
Results
Immunoreactivity for cochlin and type II collagen was observed in the spiral limbus, beneath the inner sulcus cells and the basilar membrane, beneath the epithelial cells of the spiral prominence and the spiral ligament.
Spiral Limbus
Immunolabeling of cochlin and type II collagen was observed in the fibrous area of the spiral limbus ( fig.  1 a-c) .
Inner Sulcus Cells
Immunolabeling of cochlin and type II collagen was observed in the fibrous substance beneath the inner sulcus cells ( fig. 2 a-c) .
Basilar Membrane
The structures that exhibited immunoreactivity for cochlin and type II collagen were the fibrous bundles in the basilar membrane ( fig. 3 a-c) .
Spiral Prominence
The stained fibrils for cochlin and type II collagen beneath the epithelial cells of the spiral prominence were observed to be widely scattered and without orientation ( fig. 4 a-c) . 
Spiral Ligament
Immunolabeling of cochlin and type II collagen was observed in the fibrous bundles in the spiral ligament ( fig. 5 a-c) .
Control
When pre-immune IgG was used as a negative control, the fibrillar substance of the basilar membrane exhibited no immunoreactivity ( fig. 6 ).
Discussion
Immunoreactivity for cochlin and type II collagen was observed in the same ECM areas of the cochlear duct, particularly in the following sites: the fibrous substance in the spiral limbus, beneath the inner sulcus cells, in the basilar membrane, beneath the epithelial cells of the spiral prominence and in the spiral ligament. The present study is the first report to demonstrate the localization of cochlin in these structures at the ultrastructural level. Localization of cochlin in the basilar membrane was not detected in our previous studies using the same anti-cochlin antibody at the light microscopic level Shindo et al., 2008] . This might be due to the different tissue processing and staining in the applications of light and electron microscopy. Interestingly, another antibody, which recognizes a different peptide of cochlin (residues 337-355) than the one targeted here (residues 163-181), was reactive to cochlin in this area under light microscopy [Kommareddi et al., 2007] .
Our findings for type II collagen at the basilar membrane and the spiral ligament are consistent with previous ultrastructural studies [Dreiling et al., 2002; Kaname et al., 1994 ]. At the electron microscopic level, we previously localized cochlin and type II collagen on the fibrous structures beneath the epithelial cells and supporting cells in the rat semicircular canal ]. Cochlin appears to localize with type II collagen in the fibrous structures in the ECM of the cochlea as well as in the vestibule. Nagy et al. [2008] recently demonstrated that the second vWFA-like domain of cochlin has an affinity for type II collagen. This report supports the hypothesis that these two proteins interact with each other. Several types of collagen have been detected in the ECM of the inner ear [Yoo et al., 1988; Slepecky et al., 1992; Usami et al., 2008] . Of these subtypes, type II collagen is responsible for the fibrous structure and appears to play a critical role in maintaining structural stability in the cochlea and vestibule [Slepecky et al., 1992] . Localization of these two proteins in the same fibrous substance of the ECM in the cochlear duct indicates that cochlin may play a role in the structural homeostasis of the cochlea by cross-linking to the fibrillar type II collagen bundles. Kommareddi et al. [2007] showed that a prominent 64-kDa band of cochlin co-immunoprecipitated with choline transporter-like protein 2 (CTL2). CTL2 is a multitransmembrane protein expressed on inner ear supporting cells that was discovered as a target of antibodyinduced hearing loss [Nair et al., 2004] . The present findings, together with the fact that cochlin co-immunoprecipitates with CTL2, indicate that these proteins may interact with other proteins. Indeed, cochlin and type II collagen have also been implicated as a disease-causing antigen in autoimmune hearing loss in humans [Baek et al., 2006; Yoo et al., 1984] . The association of these three proteins may therefore have very interesting implications with regard to DFNA9 pathogenesis.
In DFNA9 pathogenesis, Robertson et al. [2006] hypothesized that mutated cochlin accumulates acellular eosinophilic deposits and that this accumulation leads to degeneration of other cochlin-associated proteins. Our findings suggested that type II collagen is one of the candidates of the cochlin-associated proteins. To clarify this hypothesis, it will be interesting to analyze chronologically the ultrastructural pathology and immunohistochemistry of a mutant mouse model of DFNA9 which exhibited progressive age-related hearing loss [Robertson et al., 2008] .
The late-onset progressive sensorineural hearing loss in the DFNA9 ear also suggests a relationship between cochlin and presbycusis, an impairment of hearing characteristic of elderly individuals . Robertson et al. [2008] suggested that COCH might play important roles in presbycusis, and that cochlin is a major target antigen for autoimmune sensorineural hearing loss. The histopathologic correlates of age-related hearing loss suggest several categories for this type of auditory impairment: sensory-neural, strial, cochlear-conductive, mixed, and indeterminate [Schuknecht and Gacek, 1993] . In these categories, cochlear-conductive hearing loss may be related to pathologic change in the basilar membrane. Several studies have shown that thickening of the basilar membrane in aged animals may underlie presbycusis Shimada et al., 1998 ]. The basilar membrane is responsible for the mechanoelectrical transduction exhibited by sensory cells, which enables them to absorb stress and withstand traveling waves. This explains why changes in these mechanical properties can cause hearing impairment. Buckiova et al. [2006] have shown a reduction in type II collagen immunoreactivity at the light microscopic level in the spiral ligament, but not in the basilar membrane, of aged Fischer 344 rats (an animal model of strial presbycusis). However, the reduction of type II collagen in the spiral ligament led us to consider that degeneration of type II collagen might occur in the basilar membrane of the aging ear. The pathology of the DFNA9-affected ear includes degeneration of the basilar membrane [Khetarpal et al., 1991; Khetarpal, 1993] . At present, however, the relationship between cochlin and the age-related pathology of the inner ear remains unknown. For thin structures such as the basilar membrane, ultrastructural analysis can reveal more detailed pathology than light microscopy, and may be a better tool for determining age-related pathology. Accordingly, in the near future we plan to conduct an ultrastructural analysis of age-related changes in type II collagen and cochlin in the basilar membrane as well as in the spiral ligament.
In conclusion, the present study suggests that cochlin could cross-link to type II collagen fibers in the spiral limbus, beneath the inner sulcus cells, the basilar membrane, the spiral prominence and the spiral ligament in the cochlear duct, and that it is responsible for the structural integrity of this organ, in particular by enabling the structure to withstand the stress associated with traveling waves. Further studies, however, will be needed in order to determine the nature of the interaction between cochlin and type II collagen.
